TP53 and neoplasm: Because of the lack of a traceable tumor Ag-specific T cell response in both MCA-induced tumor models and in p53+/− mice, and development of different and unpredictable tumor types in the latter, it is difficult to correlate the presence or lack of iNKT with tumor-specific a CTL response and its involvement in cancer immune surveillance.